Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) issued its earnings results on Friday. The company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.01), RTT News reports. The firm had revenue of $7.60 million during the quarter, compared to analysts’ expectations of $6.30 million. Rapid Micro Biosystems had a negative return on equity of 45.58% and a negative net margin of 184.93%. During the same quarter last year, the business earned ($0.31) EPS. Rapid Micro Biosystems updated its FY 2024 guidance to EPS.
Rapid Micro Biosystems Trading Down 1.8 %
Shares of NASDAQ RPID opened at $1.08 on Tuesday. Rapid Micro Biosystems has a 52 week low of $0.58 and a 52 week high of $1.19. The business’s 50 day moving average price is $0.89 and its 200 day moving average price is $0.82.
Insiders Place Their Bets
In other Rapid Micro Biosystems news, Director Kirk Malloy acquired 50,000 shares of the business’s stock in a transaction dated Thursday, August 8th. The shares were purchased at an average price of $0.91 per share, for a total transaction of $45,500.00. Following the completion of the purchase, the director now directly owns 64,300 shares of the company’s stock, valued at $58,513. The trade was a 300.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 30.40% of the stock is currently owned by insiders.
Rapid Micro Biosystems Company Profile
Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Featured Articles
- Five stocks we like better than Rapid Micro Biosystems
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Is Eli Lilly a Buy? Analyst Confidence Grows for 2025
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Why Warren Buffett’s 1999 Market Warning Still Matters Today
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Medicare Advantage Costs Surge: How These 2 Insurers Are Thriving
Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
